Decoding the molecular networks of early human development
06 Feb 2024
Researchers have mapped the complex molecular interactions that occur during the earliest stages of human development.
New international research shines a light on the role of transcription factors during early embryonic development. Transcription factors are proteins that are critical for gene regulation. The study unveiled over a thousand protein-protein interactions, particularly spotlighting the previously underappreciated paired-like homeobox (PRDL) family of transcription factors that are active only in early embryonic stages.
The research is published in EMBO Reports.
New findings are key to understanding embryonic genome activation (EGA), a vital process in early development. The research paves the way for new investigations into early embryogenesis at the molecular level, with the potential to advance treatments for developmental disorders and enhance regenerative medicine.
The study also recasts homeobox gene TPRX2 thatencodes DNA-binding proteins. TPRX2 is thought to be inactive as a pseudogene, as an essential transcriptional activator in these initial phases of development.
The research gained deeper insights into the genomic binding patterns
The study also gained deeper insights into the genomic binding patterns of these transcription factors. The study revealed crucial aspects of how these proteins interact with the genome, playing a pivotal role in chromatin modification and epigenetic regulation during early embryonic development.
Beyond enhancing our fundamental comprehension of human biology, this study paves the way for investigating developmental diseases.
"We've constructed a comprehensive map of crucial protein interactions, marking a significant advancement in developmental biology and medicine. Knowing the key regulators and their association with each other's and with DNA paves way on understanding the critical early steps of human development. Still, comprehensive understanding of these processes will require further extensive research," says Dr. Markku Varjosalo from the University of Helsinki.
The study was led by Dr. Markku Varjosalo, with key contributions from international experts Professors Juha Kere and Gong-Hong Wei.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.